NDC 80425-0002-01 - Sulfamethoxazole and Trimethoprim DS
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0002
- Requested NDC
- 80425-0002-01
- Package NDCs from labels
- 80425-0002-1, 80425-0002-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sulfamethoxazole and Trimethoprim DS - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0002-1 | Sulfamethoxazole and TrimethoprimDS | 14 in 1 BOTTLE | TABLET | 14 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0002 | SULFAMETHOXAZOLE AND TRIMETHOPRIM DS (SULFAMETHOXAZOLE AND TRIMETHOPRIM) TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 1 package rows | 20250101_b000150f-3be6-2e6c-e053-2995a90a67d5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0002-1 | EA - Each | 80425-0002 | 7d6ab01e-65ee-4f48-b095-f02ac744499e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | NuCare Pharmaceuticals,Inc. | 7f82e5e0-b627-a3f3-e053-2991aa0abaa5 | 2026-02-09 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Sportpharm LLC | 52304e5e-d097-48f2-8b64-210908e4eb54 | 2026-02-03 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | REMEDYREPACK INC. | 99e1ace6-7665-4f87-82fd-5e7c4989e098 | 2026-01-13 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfameth/Trimeth-DS | SULFAMETH/TRIMETH-DS | Direct_Rx | 90026ce8-3305-6272-e053-2995a90a57e0 | 2026-01-08 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | NuCare Pharmaceuticals,Inc. | 8c3e4738-0e0a-a854-e053-2995a90a7d71 | 2026-01-05 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| SULFATRIM | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 80f7f00b-add4-4d6b-9e9c-bea29768c239 | 2026-01-05 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Northwind Health Company, LLC | f2b8e9d9-1274-22ca-e053-2a95a90a6f1a | 2026-01-01 | Warnings, Adverse reactions | 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Northwind Health Company, LLC | f7f97520-d063-ec87-e053-6294a90aae0c | 2026-01-01 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Northwind Health Company, LLC | 471c5995-a4df-fbe3-e063-6394a90aa50e | 2025-12-29 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | QPharma, Inc. | 41529314-b203-47f4-88dd-5aa57c74985f | 2025-12-02 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Major Pharmaceuticals | abe0d2d5-4879-4b4e-9b57-47ea83a17ba0 | 2025-11-18 | Warnings, Adverse reactions | 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | VERITYRX, LLC | 427b8040-99a4-8e81-e063-6394a90a76c5 | 2025-10-31 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | NuCare Pharmaceuticals,Inc. | 1274cefb-0799-e2e4-e063-6394a90aad02 | 2025-10-07 | Warnings, Adverse reactions | ANDA090624 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | American Health Packaging | 7f25bff3-0e86-4bec-b293-54b68347867f | 2025-07-23 | Warnings, Adverse reactions | ANDA090624 198334 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Somerset Therapeutics, LLC | ebb570bb-6e5e-489e-875c-9e7b3a6d716a | 2025-07-16 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Golden State Medical Supply, Inc. | bd3161fe-23d7-458a-86a4-fb958d9c94d3 | 2025-06-06 | Warnings, Adverse reactions | 198334 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | American Health Packaging | f14b8d07-e73b-4ceb-bd6a-578c961b7c09 | 2025-05-16 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 0aaf1dbe-b69d-43bd-a4ab-69cb27ab417d | 2025-05-15 | Warnings, Adverse reactions | 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Kesin Pharma | 31f9e720-3869-061f-e063-6294a90a43b4 | 2025-05-13 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Teva Parenteral Medicines, Inc. | bf7a0845-de4f-46be-841a-0faf47f8b530 | 2025-04-30 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.